1. Pharmacokinetics of ciprofloxacin

   • T. Bergan
   • A. Dalhoff
   • R. Rohwedder

   Pharmacokinetic Studies Pages: S3 - S13

2. Ciprofloxacin concentrations in tonsils following single or multiple administrations

   • N. Falser
   • A. Dalhoff
   • H. Weuta

   Pharmacokinetic Studies Pages: S14 - S18

3. Bactericidal activity of ciprofloxacin, norfloxacin and ofloxacin in serum and urine after oral administration to healthy volunteers

   • H. -J. Zeiler
   • D. Förster
   • P. Schacht

   Pharmacokinetic Studies Pages: S19 - S23

4. Single and multiple dose pharmacokinetics of ciprofloxacin in gynecological tissues

   • G. J. Gerstner
   • A. Dalhoff
   • H. Weuta

   Pharmacokinetic Studies Pages: S24 - S28

5. Worldwide clinical data on efficacy and safety of ciprofloxacin

   • P. Schacht
   • V. Chyský
   • A. Westwood

   Clinical Studies Pages: S29 - S43

6. Efficacy and safety of a single dose therapy of a 500 mg ciprofloxacin tablet in chancroid patients

   • A. Traisupa
   • C. Wongba
   • P. Tesavibul

   Clinical Studies Pages: S44 - S45

7. Efficacy of perioperative prophylaxis with ciprofloxacin or cefazolin in colorectal surgery

   • Ch. Offer
   • E. Bodner
   • H. Weuta

   Clinical Studies Pages: S46 - S47

8. Is pelvic inflammatory disease an indication for treatment with ciprofloxacin?

   • D. Hägele
   • V. Chyský

   Clinical Studies Pages: S48 - S50

9. Antibacterial treatment of otitis and sinusitis with ciprofloxacin and penicillin V — A comparison

   • N. Falser
   • H. Mittermayer
   • H. Weuta

   Clinical Studies Pages: S51 - S54

10. Bacterial infections of the skin treated with ciprofloxacin

    • A. Gorkiewicz-Petkow
    • S. Jablonska
    • H. Weuta

    Clinical Studies Pages: S55 - S56

11. Efficacy and safety of ciprofloxacin in the treatment of UTIs and RTIs in patients affected by liver diseases

    • S. Esposito
    • D. Galante
    • R. Gagliardi

    Clinical Studies Pages: S57 - S61

12. Bacterial infections of the lower urinary tract treated with ciprofloxacin or cefalexin — a comparative study

    • A. Polubiec
    • K. Stepka
    • H. Weuta

    Clinical Studies Pages: S62 - S64

13. Haemostasis during treatment with ciprofloxacin

    • M. Ziemen
    • K. Breddin
    • P. M. Shah

    Clinical Studies Pages: S65 - S68

14. Investigation on renal tolerability of ciprofloxacin with tests based on monoclonal antibodies

    • F. W. Falkenberg
    • A. W. Mondorf

    Clinical Studies Pages: S69 - S75

15. The following papers on cirpofloxacin have appeared in Infection 1983–1988

    Legacy Pages: S76 - S76